Published in Biotech Business Week, September 19th, 2005
Baird Venture Partners led the investment with Affinity Capital Management and Fisk Ventures joining the syndicate. Existing investors Delphi Ventures, Alloy Ventures, Johnson & Johnson Development Corporation, Three Arch Partners, Thomas J. Fogarty MD, Sapient Capital, Kaiser Venture Capital, David Chonette, and Sage Venture Partners, also participated in this round of financing. With the closing of this round, Arbor has raised approximately $34 million dollars to date.
In conjunction with the financing, Pete Shagory of Baird Venture Partners has joined Arbor's board...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.